Uremia

New England Journal of Medicine

Volumn 282, Issue 17, 1970, Pages 953-961

  Merrill, John P ^a   Hampers, Constantine L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; LIPID; PROTEIN; URIC ACID;

ACIDOSIS; EYE DISEASE; GASTROINTESTINAL DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; KIDNEY CONCENTRATING CAPACITY; METABOLISM; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PH; REVIEW; SKIN MANIFESTATION; UREMIA;

ACIDOSIS; CARBOHYDRATES; EYE DISEASES; GASTROINTESTINAL DISEASES; GLOMERULAR FILTRATION RATE; HUMAN; HYDROGEN-ION CONCENTRATION; KIDNEY; KIDNEY CONCENTRATING ABILITY; LIPIDS; NERVOUS SYSTEM DISEASES; PROTEINS; SKIN MANIFESTATIONS; UREMIA; URIC ACID;

EID: 0014959339     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197004232821706     Document Type: Review

References (82)

1. Schreiner GE, Maher JF: Uremia: Biochemistry, pathogenesis and treatment. Springfield, Illinois, Charles C Thomas, 1961
2. Hampers CL, Schupak E: Long-Term Hemodialysis: The management of the patient with chronic renal failure. New York, Grune and Stratton, 1967
3. Merrill JP: The Treatment of Renal Failure: Therapeutic principles in the management of acute and chronic uremia. Second edition. New York, Grune and Stratton, 1965
4. Nutrition in Renal Disease: Proceedings of a conference held at the University of Manchester on June 29–30, 1967. Edited by GM Berlyne. Edinburgh, E and S Livingstone Ltd, 1968
5. Welt LG: Symposium on uremia: introduction. Amer J Med 44: 653–655, 1968
6. Platt R: Structural and functional adaptation in renal failure. Brit Med J 1: 1313–1317, 1952
7. Bricker NS, Morrin PAF, Kime SW Jr: The pathologic physiology of chronic Bright's disease: an exposition of the “intact nephron hypothesis.” Amer J Med 28: 77–98, 1960
8. Franklin SS, Merrill JP: The kidney in health: the nephron in disease. Amer J Med 28: 1–7, 1960
9. Biber TUL, Mylle M, Baines AD, et al: A study by micropuncture and microdissection of acute renal damage in rats. Amer J Med 44: 664–705, 1968
10. Bricker NS: On the meaning of the intact nephron hypothesis. Amer J Med 46: 1–11, 1969
11. Slatopolsky E, Gradowska L, Kashemsant C, et al: The control of phosphate excretion in uremia. J Clin Invest 45: 672–677, 1966
12. Schultze RG, Shapiro HS, Bricker NS: Studies on the control of sodium excretion in experimental uremia. J Clin Invest 48: 869–877, 1969
13. Bricker NS, Klahr S, Bourgoignie J, et al: On a circulating inhibitor of sodium transport in uremia. Presented at the Fourth International Congress of Nephrology, Stockholm, June 22–27, 1969, p 173
14. Preuss HG, Massry SG, Maher JF, et al: Effects of uremia sera on renal tubular p-aminohippurate transport. Nephron 3: 265–273, 1966
15. Hook JB, Munro JR: Specificity of the inhibitory effect of “uremic” serum on p-aminohippurate transport. Proc Soc Exp Biol Med 127: 289–292, 1968
16. Kleeman CR, Okun R, Heller RJ: The renal regulation of sodium and potassium in patients with chronic renal failure (CRF) and the effect of diuretics on the excretion of these ions. Ann NY Acad Sci 139: 520–539, 1966
17. Hayslett JP, Kashgarian M, Epstein FH: Mechanism of change in the excretion of sodium per nephron when renal mass is reduced. J Clin Invest 48: 1002–1006, 1969
18. Coleman AJ, Arias M, Carter NW, et al: The mechanism of salt wastage in chronic renal disease. J Clin Invest 45: 1116–1125, 1968
19. Alexander EA, Levinsky NG: An extrarenal mechanism of potassium adaptation. J Clin Invest 47: 740–748, 1968
20. Hayslett JP, Boyd JE, Epstein FH: Aldosterone production in chronic renal failure. Proc Soc Exp Biol Med 130: 912–914, 1969
21. Gerstein AR, Kleeman ChR, Gold EM, et al: Aldosterone deficiency in chronic renal failure. Nephron 5: 90–105, 1968
22. Rieselbach RE, Shankel SW, Slatopolsky E, et al: Glucose titration studies in patients with chronic progressive renal disease. J Clin Invest 46: 157–163, 1967
23. Shankel SW, Robson AM, Bricker NS: On the mechanism of the splay in the glucose titration curve in advanced experimental renal disease in the rat. J Clin Invest 46: 164–172, 1967
24. Halperin ML, Connors HP, Relman AS, et al: Factors that control the effect of pH on glycolysis in leukocytes. J Biol Chem 244: 384–390, 1969
25. Walker BG, Phear DN, Martin FIR, et al: Inhibition of insulin by acidosis. Lancet 2: 964–965, 1963
26. Welt LG: A further evaluation of erythrocyte sodium transport in control subjects and patients with uremia. Nephron 6: 406–417, 1969
27. Shohet SB, Gardner FH: Tissue culture of primitive human myeloid cells for the study of cellular proliferation: preliminary report on a growth inhibitor in the heated serum of two patients with chronic myelogenous leukemia (CML) following splenic irradiation. Blood 31: 180–187, 1968
28. White AG: Uremic serum inhibition of renal paraaminohippurate transport. Proc Soc Exp Biol Med 123: 309–310, 1966
29. Podevin R, Paillard F, Richet G: Action of uremic serum on uric acid 2–14C transport by isolated renal tubules. Presented at the Fourth International Congress of Nephrology, Stockholm, June 22–27, 1969, p 49
30. Renner D, Heinz R: Cell metabolism in uremia. Presented at the Fourth International Congress of Nephrology, Stockholm, June 22–27, 1969, p 42
31. Welt G: Red cell sodium pump and uremia. Presented at the Fourth International Congress of Nephrology, Stockholm, June 22–27, 1969, p 46
32. Bittar EE: The effect of uremic plasma on the efflux of sodium from the toad oocyte. Presented at the Fourth International Congress of Nephrology, Stockholm, June 22–27, 1969, p 47
33. Giovannetti S, Biagini M, Balestri PL, et al: Uraemic symptoms in dogs chronically intoxicated with methylguanidine. Presented at the Fourth International Congress of Nephrology, Stockholm, June 22–27, 1969, p 43
34. Cohen BD: Guanidine retention and the urea cycle. Presented at the Fourth International Congress of Nephrology, Stockholm, June 22–27, 1969, p 45
35. Tyler HR: Neurologic disorders in renal failure. Amer J Med 44: 734–748, 1968
36. Kennedy Achéal, Linton AL, Luke RG, et al: Electroencephalographic changes during haemodialysis. Lancet 1: 408–411, 1963
37. Weiler JM, Swan RC, Merrill JP: Changes in acid–base balance of uremic patients during hemodialysis. J Clin Invest 32: 729–735, 1953
38. Hampers CL, Doak PB, Callaghan MN, et al: The electroencephalogram and spinal fluid during hemodialysis. Arch Intern Med (Chicago) 118: 340–346, 1966
39. Scheinberg P: Effects of uremia on cerebral blood flow and metabolism. Neurology (Minneap) 4: 101–105, 1954
40. Callaghan N: Restless legs syndrome in uremic neuropathy. Neurology (Minneap) 16: 359–361, 1966
41. Blagg CR, Kemble F. Taverner D: Nerve conduction velocity in relationship to the severity of renal disease. Nephron 5: 290–299, 1968
42. Berlyne GM, Shaw AB: Red eyes in renal failure. Lancet 1: 4–7, 1967
43. Wrong O: The metabolism of urea and ammonia in the healthy and uraemic colon. Med J Aust 2: 281–283, 1967
44. Hampers CL. Katz AI, Wilson RE, et al: Disappearance of “uremic” itching after subtotal parathyroidectomy. New Eng J Med 279: 695–697, 1968
45. Carpenter CB, Glassock RJ, Corson JM, et al: The application of the normal lymphocyte transfer reaction to histocompatibility testing in man. J Clin Invest 45: 1452–1466, 1966
46. Balch HH: The effect of severe battle injury and of post-traumatic renal failure on resistance to infection. Ann Surg 142: 145–163, 1955
47. Myers VC, Killian JA: Studies on animal diastases. I. The increased diastatic activity of the blood in diabetes and nephritis. J Biol Chem 29: 179–189, 1917
48. Cohen BD: Abnormal carbohydrate metabolism in renal disease: blood glucose unresponsiveness to hypoglycemia, epinephrine, and glucagon. Ann Intern Med 57: 204–213, 1962
49. Hampers CL, Soeldner JS, Doak PB, et al: Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest 45: 1719–1731, 1966
50. Briggs JD, Buchanan KD, Luke RG, et al: Role of insulin in glucose intolerance in uraemia. Lancet 1: 462–464, 1967
51. Perkoff GT, Thomas CL, Newton JD, et al: Mechanism of impaired glucose tolerance in uremia and experimental hyperazotemia. Diabetes 7: 375–383, 1958
52. Harris JI: Effect of urea on trypsin and alpha-chymotrypsin. Nature (London) 177: 471–473, 1956
53. Hutchings RH, Hegstrom RM, Scribner BH: Glucose intolerance in patients on long-term intermittent dialysis. Ann Intern Med 65: 275–285, 1966
54. Davidson MB, Lowrie EG, Hampers CL: Lack of dialyzable insulin antagonist in uremia. Metabolism 18: 387–394, 1969
55. Tchobroutsky G, de L'Hortet GC, Rosselin G, et al: Étude de la glycorégulation dans l'insuffisance rénale chronique 1. Diabetologia 1: 101–108, 1965
56. Klink DD, Meade RC, Roth DA: Insulin response to glucose in azotemia. Diabetes 14: 459, 1965
57. Alfrey Achéal, Sussman KE, Holmes JH: Changes in glucose and insulin metabolism induced by dialysis in patients with chronic uremia. Metabolism 16: 733–740, 1967
58. O'Brien JP. Sharpe AR Jr: The influence of renal disease on the insulin I131 disappearance curve in man. Metabolism 16: 76–83, 1967
59. Borst JGG: Protein katabolism in uraemia: effects of protein-free diet, infections, and blood-transfusions. Lancet 1: 824–829, 1948
60. Shaw AB, Bazzard FJ, Booth EM, et al: The treatment of chronic renal failure by a modified Giovannetti diet. Quart J Med 34: 237–253, 1965
61. Farr LE, Smadel JE: The effect of dietary protein on the course of nephrotoxic nephritis in rats. J Exp Med 70: 615–627, 1939
62. Addis T: Glomerular Nephritis: Diagnosis and treatment. New York, Macmillan Company, 1948
63. Kopple JD, Shinaberger JH, Coburn JW, et al: Protein nutrition in uremia: a review. Amer J Clin Nutr 21: 508–515, 1968
64. Watkin DM, Froeb HF, Hatch FT, et al: Effects of diet in essential hypertension. II. Results with unmodified Kempner rice diet in fifty hospitalized patients. Amer J Med 9: 441–493, 1950
65. McCormick GJ, Shear L, Barry KG: Alteration of hepatic protein synthesis in acute uremia. Proc Soc Exp Biol Med 122: 99–102. 1966
66. Herndon RF, Freeman S, Cleveland AS: Protein requirements in chronic renal insufficient patients: a study of the nitrogen minimum. J Lab Clin Med 52: 235–246, 1958
67. Smith M: A case of chronic nephritis maintained for six months on an average daily protein intake of 0.26 grams per kilogram of body weight. Boston Med Surg J 196: 941–946, 1927
68. Kempner W: Compensation of renal metabolic dysfunction: treatment of kidney disease and hypertensive vascular disease with rice diet. III. N Carolina Med J 6: 61–87, 1945
69. Giordano C: Use of exogenous and endogenous urea for protein synthesis in normal and uremic subjects. J Lab Clin Med 62: 231–246, 1963
70. Giordano C, Esposito R, de Santo C, et al: Dietary treatment in renal failure, Proceedings of the Third International Congress of Nephrology, Washington, DC, September 25–30, 1966. Vol 3. Clinical Nephrology. Edited by GE Schreiner. Basel, S Karger. 1967, pp 214–229
71. Giovannetti S. Maggiore Q: A low-nitrogen diet with proteins of high biological value for severe chronic uraemia. Lancet 1: 1000–1003, 1964
72. Berlyne GM, Shaw AB, Nilwarangkur S: Dietary treatment of chronic renal failure: experiences with a modified Giovannetti diet. Nephron 2: 129–147, 1965
73. Franklin SS, Gordon A, Kleeman CR, et al: Use of a balanced low-protein diet in chronic renal failure. JAMA 202: 447–484, 1967
74. Berlyne GM, Shaw AB: Giordano-Giovannetti diet in terminal renal failure. Lancet 2: 7–9, 1965
75. Muting D, Dishuk BD: Free amino acids in serum, cerebrospinal fluid, and urine in renal disease with and without uremia. Proc Soc Exp Biol Med 126: 754–758, 1967
76. Christensen HN: Biological Transport. New York, WA Benjamin Inc, 1962
77. Gulyassy PF, Peters JH, Lin SC, et al: Hemodialysis and plasma amino acid composition in chronic renal failure. Amer J Clin Nutr 21: 565–573, 1968
78. Hood CEA, Beale DJ. Housley J, et al: Dialysed egg as nitrogen source in dietary control of chronic renal failure. Lancet 1: 479–482, 1969
79. Bagdade JD, Porte D Jr. Bierman EL: Hypertriglyceridemia: a metabolic consequence of chronic renal failure. New Eng J Med 279: 181–185, 1968
80. Caner JEZ, Decker JL: Recurrent acute (?gouty) arthritis in chronic renal failure treated with periodic hemodialysis. Amer J Med 36: 571–582, 1964
81. Relman AS: The acidosis of renal disease. Amer J Med 44: 706–713, 1968
82. Schwartz WB, Hall PW III, Hays R, et al: On the mechanism of acidosis in chronic renal disease. J Clin Invest 38: 39–52, 1959